Department of Health Policy and Management.
The Hospital And Public health interdisciPlinarY research (HAPPY) Lab.
Med Care. 2023 Jan 1;61(1):27-35. doi: 10.1097/MLR.0000000000001794. Epub 2022 Nov 7.
Alzheimer disease and related dementia (ADRD) is one of the most expensive health conditions in the United States. Understanding the potential cost-savings or cost-enhancements of Health Information Technology (HIT) can help policymakers understand the capacity of HIT investment to promote population health and health equity for patients with ADRD.
This study examined access to hospital-based HIT infrastructure and its association with racial and ethnic disparities in Medicare payments for patients with ADRD.
We used the 2017 Medicare Beneficiary Summary File, inpatient claims, and the American Hospital Association Annual Survey. Our study focused on community-dwelling Medicare fee-for-service beneficiaries who were diagnosed with ADRD. Our study focused on hospital-based telehealth-postdischarge (eg, remote patient monitoring) and telehealth-treatment (eg, psychiatric and addiction treatment) services.
Results showed that hospital-based telehealth postdischarge services were associated with significantly higher total Medicare payment and acute inpatient Medicare payment per person per year among patients with ADRD on average. The associations between hospital-based telehealth-treatment services and payments were not significant. However, the association varied by patient's race and ethnicity. The reductions of the payments associated with telehealth postdischarge and treatment services were more pronounced among Black patients with ADRD. Telehealth-treatment services were associated with significant payment reductions among Hispanic patients with ADRD.
Results showed that having hospital-based telehealth services might be cost-enhancing at the population level but cost-saving for Black and Hispanic patients with ADRD. Results suggested that personalized HIT services might be necessary to reduce the cost associated with ADRD treatment for racial and ethnic minority groups.
阿尔茨海默病和相关痴呆症(ADRD)是美国最昂贵的健康状况之一。了解健康信息技术(HIT)的潜在节省成本或增加成本的可能性,可以帮助政策制定者了解 HIT 投资促进 ADRD 患者人群健康和健康公平的能力。
本研究考察了医院 HIT 基础设施的可及性及其与 ADRD 患者医疗保险支付的种族和民族差异之间的关联。
我们使用了 2017 年医疗保险受益摘要文件、住院索赔和美国医院协会年度调查。我们的研究重点是患有 ADRD 的居住在社区的医疗保险按服务付费受益人。我们的研究重点是基于医院的远程医疗出院后(例如,远程患者监测)和远程医疗治疗(例如,精神科和成瘾治疗)服务。
结果表明,平均而言,患有 ADRD 的患者中,基于医院的远程医疗出院后服务与医疗保险总支付和急性住院医疗保险支付显著相关。基于医院的远程医疗治疗服务与支付之间的关联不显著。然而,这种关联因患者的种族和民族而异。与远程医疗出院后和治疗服务相关的支付减少在 ADRD 的黑人患者中更为明显。远程医疗治疗服务与 ADRD 的西班牙裔患者的显著支付减少有关。
结果表明,在人群层面上,拥有基于医院的远程医疗服务可能会增加成本,但对 ADRD 的黑人和西班牙裔患者而言则可以节省成本。结果表明,可能需要个性化的 HIT 服务,以减少少数民族群体 ADRD 治疗相关的成本。